US medical device maker Stryker will buy smaller rival Wright Medical in a deal worth $5.4bn including debt as it seeks to boost its exposure to the fast-growing orthopaedics market.  Michigan-headquartered Stryker said on Monday that it would pay $30.75 per share for Wright Medical, a near 40 per cent premium to Friday’s closing share price. The deal has an equity value of $4bn, with a total enterprise value of approximately $5.4bn.


Read More Financial Times: 

Add Your Thoughts

Your email address will not be published.